These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Risk markers for contrast-induced nephropathy. Toprak O Am J Med Sci; 2007 Oct; 334(4):283-90. PubMed ID: 18030185 [TBL] [Abstract][Full Text] [Related]
26. Contrast-induced nephropathy remains a serious complication of PCI. Mehran R J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117 [No Abstract] [Full Text] [Related]
27. Percutaneous coronary intervention complications and guide catheter size: bigger is not better. Grossman PM; Gurm HS; McNamara R; Lalonde T; Changezi H; Share D; Smith DE; Chetcuti SJ; Moscucci M; JACC Cardiovasc Interv; 2009 Jul; 2(7):636-44. PubMed ID: 19628187 [TBL] [Abstract][Full Text] [Related]
28. Contrast-induced nephropathy morbidity and mortality following percutaneous coronary intervention. Brown JR; Solomon RJ Am J Cardiol; 2009 Dec; 104(12):1763. PubMed ID: 19962490 [No Abstract] [Full Text] [Related]
29. N-acetylcysteine and contrast-induced nephropathy. Balderramo DC N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740 [No Abstract] [Full Text] [Related]
30. Contrast-induced monoplegia following coronary angioplasty with iopromide. Aykan A; Zehir R; Karabay CY; Kocabay G Kardiol Pol; 2012; 70(5):499-500. PubMed ID: 22623245 [TBL] [Abstract][Full Text] [Related]
31. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387 [TBL] [Abstract][Full Text] [Related]
32. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Wróbel W; Sinkiewicz W; Gordon M; Woźniak-Wiśniewska A Kardiol Pol; 2010 Sep; 68(9):1015-20. PubMed ID: 20859892 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic strategy for prevention of contrast-induced nephropathy]. Suzuki H Nihon Rinsho; 2011 Sep; 69 Suppl 7():220-5. PubMed ID: 22518995 [No Abstract] [Full Text] [Related]
34. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy. Bouzas-Mosquera A; Recio-Mayoral A Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455 [No Abstract] [Full Text] [Related]
35. N-acetylcysteine and contrast-induced nephropathy. Ritz E N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738 [No Abstract] [Full Text] [Related]
36. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions. Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445 [TBL] [Abstract][Full Text] [Related]